carbamazepine and nateglinide

carbamazepine has been researched along with nateglinide in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's4 (80.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Bauer, S; Brockmöller, J; Kirchheiner, J; Michael, C; Roots, I; Störmer, E1
Bansal, AK; Dantuluri, AK; Kumar, L; Upadhyay, P1

Reviews

1 review(s) available for carbamazepine and nateglinide

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for carbamazepine and nateglinide

ArticleYear
Rapid and simple method for the analysis of nateglinide in human plasma using HPLC analysis with UV detection.
    Journal of pharmaceutical and biomedical analysis, 2003, Mar-10, Volume: 31, Issue:3

    Topics: Anticonvulsants; Calibration; Carbamazepine; Chromatography, High Pressure Liquid; Cyclohexanes; Humans; Hypoglycemic Agents; Indicators and Reagents; Nateglinide; Phenylalanine; Quality Control; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet

2003

Other Studies

3 other study(ies) available for carbamazepine and nateglinide

ArticleYear
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Estimating relative stability of polymorphs by generation of configurational free energy phase diagram.
    Journal of pharmaceutical sciences, 2012, Volume: 101, Issue:5

    Topics: Calorimetry, Differential Scanning; Carbamazepine; Cyclohexanes; Models, Theoretical; Nateglinide; Phenylalanine; Powder Diffraction; Solubility; Thermodynamics

2012